25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Non-diabetic wounds<br />

First Author and<br />

Year of Publication<br />

NHMRC<br />

Level<br />

Study Design Location<br />

Dates of<br />

Enrolment Size<br />

Characteristics of Study Population †<br />

Age (years)<br />

Mean (SD)<br />

Hammarlund<br />

1994 51 II RCT Sweden ? ‡ 16 67 (42-75) 9:7<br />

Sex Ratio<br />

(M:F)<br />

* Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard<br />

deviation.<br />

† <strong>Information</strong> is given for treatment and control groups, if available. Otherwise, total study population values are stated.<br />

‡ Unstated, unclear, or unknown.<br />

Necrotising soft tissue infections: general<br />

First Author and<br />

Year of Publication<br />

Brown 1994 52<br />

Riseman 1990 53<br />

NHMRC<br />

Level<br />

Study Design Location<br />

III-2 Comparative study Canada<br />

III-3<br />

Comparative study<br />

with historical<br />

controls<br />

USA<br />

Dates of<br />

Enrolment Size<br />

Jan 1980<br />

to Dec<br />

1991<br />

1980 to<br />

1988<br />

Characteristics of Study Population †<br />

Age (years)<br />

Mean (SD)<br />

Sex Ratio<br />

(M:F)<br />

98 <strong>Hyperbaric</strong> oxygen therapy<br />

54<br />

29<br />

I=51.3 (17.1)<br />

C=61.6 (12.6)<br />

I=59.7 (14-82) ‡<br />

C=68.5 (41-88)<br />

I=22:8<br />

C=13:11<br />

I=11:6<br />

C=7:5<br />

* Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard<br />

deviation.<br />

† <strong>Information</strong> is given for intervention and comparison groups, if available. Otherwise, total study population values are stated.<br />

‡ Figures in parentheses are ranges.<br />

Necrotising soft tissue infections: necrotising fasciitis<br />

First Author and<br />

Year of Publication<br />

Shupak 1995 54<br />

Sawin 1994 55<br />

Barzilai 1985 56<br />

NHMRC<br />

Level<br />

Study Design Location<br />

III-2 Comparative study Israel<br />

III-2 Comparative study USA<br />

III-2 Comparative study Israel<br />

Dates of<br />

Enrolment Size<br />

1984 to<br />

1993<br />

Jan 1982<br />

to Mar<br />

1993<br />

1979 to<br />

1983<br />

Characteristics of Study Population †<br />

37<br />

Age (years)<br />

Mean (SD)<br />

I=52.9 (15)<br />

C=57.4 (16)<br />

7 9 days (3-15) § ?<br />

11<br />

I=48.33 (12.5)<br />

C=55.88 (9.2)<br />

Sex Ratio<br />

(M:F)<br />

I=14:11<br />

C=9:3<br />

I=3:0<br />

C=6:2<br />

* Abbreviations: C = comparison group, F = female, I = intervention group, M = male, RCT = randomised controlled trial, SD = standard<br />

deviation.<br />

† <strong>Information</strong> is given for intervention and comparison groups, if available. Otherwise, total study population values are stated.<br />

‡ Unstated, unclear, or unknown.<br />

§ Figures in parentheses are ranges.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!